- Academic Registry
Programme & Unit Catalogues

BB50255: Medical biotechnology

[Page last updated: 15 October 2020]

Follow this link for further information on academic years Academic Year: 2020/1
Further information on owning departmentsOwning Department/School: Department of Biology & Biochemistry
Further information on credits Credits: 15      [equivalent to 30 CATS credits]
Further information on notional study hours Notional Study Hours: 300
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Academic Year
Further information on unit assessment Assessment Summary: CW 50%, EX 50%
Further information on unit assessment Assessment Detail:
  • Research Presentation (CW 50%)
  • Synoptic Written Examination (EX 50%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Description: Aims:
This unit is aimed at students interested in analysing the strengths and limitations of proteomic technologies and the application of structural biology data in medicine.

Learning Outcomes:
By the end of this unit you will be able to:
* Demonstrate a critical and integrated overview of the key processes controlling the production and turnover of cellular proteins;
* Evaluate and analyse the strengths and limitations of proteomic technologies and application of structural biology data in medicine;
* Critically evaluate the wider applications of enzymes in biotechnology & medicine;
* Examine the impact of genome sequencing and recombinant DNA technologies on the potential application of enzymes in medicine;
* Communicate your critical evaluation and analyses through a formal presentation.

Topics include protein folding, post-translational modifications and turnover, computational approaches to proteomics, enzyme engineering; biosensors; enzyme chaperones; clinical enzymology; enzyme therapy; enzymes as target for drugs; catalytic antibodies; extremozymes.
Further information on programme availabilityProgramme availability:

BB50255 is Optional (DEU) on the following programmes:

Department of Biology & Biochemistry
  • RSBB-AFM49 : Integrated PhD Molecular Biosciences (Biotechnology)
  • TSBB-AFM49 : MSc Molecular Biosciences (Biotechnology)


  • This unit catalogue is applicable for the 2020/21 academic year only. Students continuing their studies into 2021/22 and beyond should not assume that this unit will be available in future years in the format displayed here for 2020/21.
  • Programmes and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Find out more about these and other important University terms and conditions here.